Vascular Solutions, INC.
Reporting payments is a legal requirement; large totals often reflect large product portfolios.
$1.2Mgeneral payments (2019-2025)
$12Kresearch payments (2019-2025)
20clinicians paid
General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.
General payments by year
General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.
Specialties it works with most
Clinicians with the largest reported totals
Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.
| Clinician | Location | Specialty | General payments (2019-2025) |
|---|---|---|---|
| Jeffrey Chambers | Minneapolis, MN | Cardiovascular Disease | $841,634.04 |
| Craig Greben | Manhasset, NY | Vascular & Interventional Radiology | $173,611.86 |
| Eric Gandras | Manhasset, NY | Vascular & Interventional Radiology | $47,065.98 |
| Thom Dahle | Saint Cloud, MN | Interventional Cardiology | $26,098.46 |
| David Daniels | Burlingame, CA | Interventional Cardiology | $15,152.50 |
| William Lombardi | Seattle, WA | Interventional Cardiology | $12,440.21 |
| Kathleen Kearney | Seattle, WA | Interventional Cardiology | $7,613.04 |
| Gautam Kumar | Atlanta, GA | Cardiovascular Disease | $6,473.05 |
| Duane Pinto | Boston, MA | Interventional Cardiology | $6,000.00 |
| Kevin Croce | Chestnut Hill, MA | Cardiovascular Disease | $5,997.14 |
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.